Location: Home
  • search
  • go
  • Relate News
  • 11/20/2019Chinese Non-prescription Drug Sales Set to Reach CNY 250B by 2020
  • 11/20/2019LIDDS licensee Jiangxi Puheng Pharma Prepares for Phase III Trial in C...
  • 11/20/2019Mundipharma Accused of Using Fake Doctors, Misleading Claims to Drive ...
  • 11/19/2019Xian Janssen: Embrace Better Future with New Solutions
  • 11/19/2019WuXi AppTec's LTD Expands Toxicology Facility in China
  • 11/18/2019Novartis Closes Early Drug Discovery R&D Unit in China
  • 11/18/20193SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 As First Pro...
  • 11/18/2019Chinese Import of Medicines Up Only 1.6% in 3Qs/2019
  • 11/18/2019Listed Chinese MedPharm Companies Report Slower Growth in Q3
  • 11/18/2019CNMA Publishes 2019 Top 100 OTC Drug Manufacturer Ranking
  • 11/16/2019Former Deputy CFDA Commissioner Sentenced to 16 Years in Prison
  • 11/16/2019Hua Medicine Stock Sheds 40% Over Efficacy Concerns of Its Novel Diabe...
  • 11/16/2019RemeGen Announces Positive Results from Phase IIb Trial of SLE Drug
  • 11/16/2019Recent Executive Moves
  • 11/15/2019State Council Announces Promotion of Healthcare Reform Experience of F...
  • 11/15/2019CDE Accepts Lilly's NDA for Verzenio (Abemaciclib)
  • 11/15/2019U.S. FDA Grants BeiGene's BRUKINSA (zanubrutinib) Accelerated Approval...
  • 11/14/2019China to Launch Nationwide Vaccine Tracking System Next Year
  • 11/14/2019Outlook on Chinese Pharma Distribution Market 2019-2025
  • 11/13/2019Thermo Fisher Opens Customer Solution Center in China
  • 11/13/2019Upcoming Event: Asia Wellness Expo 2020
  • 11/13/2019Upcoming Event: NanoPharma 2020
  • 11/13/2019China Issues the Provisions for Health Insurance Administration
  • 11/13/2019Upcoming Event: IDF Congress 2019
  • 11/13/2019CDE Solicits Comments on the Working Procedures for Risk Control, Susp...
  • 11/13/2019Pharmaceutical Innovation in the APAC Region
  • 11/13/2019Upcoming Event: Phar-East 2020
  • 11/13/2019LEO Pharma, HitGen to Develop Novel Class of Derma Drugs
  • 11/13/2019Hua Medicine's Pivotal Phase III Monotherapy Trial of Dorzagliatin
  • 11/13/2019Qpex Biopharma, Brii Biosciences Ink Anti-infective Alliance for China
  • Page:204/720 Total number of articles:21572: [First][<<] [202] [203] [204] [205] [206] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group